A Smoothed Version of the Lassosum Penalty for Fitting Integrated Risk Models Using Summary Statistics or Individual-Level Data.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
06 01 2022
Historique:
received: 11 11 2021
revised: 03 01 2022
accepted: 04 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 23 2 2022
Statut: epublish

Résumé

Polygenic risk scores are a popular means to predict the disease risk or disease susceptibility of an individual based on its genotype information. When adding other important epidemiological covariates such as age or sex, we speak of an integrated risk model. Methodological advances for fitting more accurate integrated risk models are of immediate importance to improve the precision of risk prediction, thereby potentially identifying patients at high risk early on when they are still able to benefit from preventive steps/interventions targeted at increasing their odds of survival, or at reducing their chance of getting a disease in the first place. This article proposes a smoothed version of the "Lassosum" penalty used to fit polygenic risk scores and integrated risk models using either summary statistics or raw data. The smoothing allows one to obtain explicit gradients everywhere for efficient minimization of the Lassosum objective function while guaranteeing bounds on the accuracy of the fit. An experimental section on both Alzheimer's disease and COPD (chronic obstructive pulmonary disease) demonstrates the increased accuracy of the proposed smoothed Lassosum penalty compared to the original Lassosum algorithm (for the datasets under consideration), allowing it to draw equal with state-of-the-art methodology such as LDpred2 when evaluated via the AUC (area under the ROC curve) metric.

Identifiants

pubmed: 35052450
pii: genes13010112
doi: 10.3390/genes13010112
pmc: PMC8775060
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL089897
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL089856
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL089897
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600031C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL117620
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL120393
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL120393
Pays : United States

Références

Genet Med. 2019 Aug;21(8):1705-1707
pubmed: 30635622
Nat Commun. 2021 Jul 7;12(1):4192
pubmed: 34234142
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Bioinformatics. 2020 Dec 16;:
pubmed: 33326037
Nat Commun. 2019 Nov 8;10(1):5086
pubmed: 31704910
Nat Commun. 2019 Jul 25;10(1):3328
pubmed: 31346163
COPD. 2010 Feb;7(1):32-43
pubmed: 20214461
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
J Thorac Oncol. 2010 Sep;5(9):1315-6
pubmed: 20736804
Nat Genet. 2018 Sep;50(9):1318-1326
pubmed: 30104760
BMC Genet. 2015 Dec 03;16:138
pubmed: 26634245
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
PLoS Med. 2018 Mar 30;15(3):e1002546
pubmed: 29601582
Gigascience. 2019 Jul 1;8(7):
pubmed: 31307061
BMC Med Genomics. 2020 Nov 3;13(1):164
pubmed: 33143703
Genet Epidemiol. 2020 Mar;44(2):125-138
pubmed: 31922285
Nature. 2021 Mar;591(7849):211-219
pubmed: 33692554
Behav Genet. 2016 Jul;46(4):573-82
pubmed: 26747043
Nat Commun. 2020 Sep 23;11(1):4799
pubmed: 32968074
J Child Psychol Psychiatry. 2014 Oct;55(10):1068-87
pubmed: 25132410
Nat Commun. 2019 Apr 16;10(1):1776
pubmed: 30992449
Can J Cardiol. 2017 Apr;33(4):422-424
pubmed: 28129965
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
J Hum Genet. 2021 Apr;66(4):359-369
pubmed: 33009504
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Nat Genet. 2019 Mar;51(3):404-413
pubmed: 30617256
Am J Hum Genet. 2015 Oct 1;97(4):576-92
pubmed: 26430803
Genet Epidemiol. 2017 Sep;41(6):469-480
pubmed: 28480976
Nat Protoc. 2020 Sep;15(9):2759-2772
pubmed: 32709988
J Pers Med. 2016 Jan 14;6(1):
pubmed: 26784234
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560

Auteurs

Georg Hahn (G)

Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA 02115, USA.

Dmitry Prokopenko (D)

Genetics and Aging Research Unit, McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.

Sharon M Lutz (SM)

Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA 02115, USA.

Kristina Mullin (K)

Genetics and Aging Research Unit, McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.

Rudolph E Tanzi (RE)

Genetics and Aging Research Unit, McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.

Michael H Cho (MH)

Department of Medicine, Brigham and Women's Hospital, Harvard University, Boston, MA 02115, USA.

Edwin K Silverman (EK)

Department of Medicine, Brigham and Women's Hospital, Harvard University, Boston, MA 02115, USA.

Christoph Lange (C)

Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH